These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 213698)

  • 1. Studies on the neutralization of herpes simplex virus. IX. Variance in complement requirement among IgG and IgM from early and late sera under different sensitization conditions.
    Yoshino K; Isono N
    Microbiol Immunol; 1978; 22(7):403-14. PubMed ID: 213698
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the neutralization of herpes simplex virus. XI. Differences between slow-reacting complement-requiring neutralizing (s-CRN) antibodies in IgG and IgM.
    Yoshino K; Urayama M; Abe K
    Microbiol Immunol; 1980; 24(11):1069-77. PubMed ID: 6261091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the neutralization of herpes simplex virus. VIII. Significance of viral sensitization for inactivation by complement.
    Yoshino K; Hashimoto M; Shinkai K
    Microbiol Immunol; 1977; 21(4):231-41. PubMed ID: 195185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rheumatoid factor and anti-immunoglobulin G antibodies on complement-mediated lysis of herpes simplex virus-infected human fibroblasts.
    Shivers JC; Daniels CA
    Infect Immun; 1977 Feb; 15(2):478-84. PubMed ID: 191401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibodies of the IgG and IgM classes to herpes simplex virus type 1 in cerebrospinal fluid and serum from four patients with herpes encephalitis.
    Rapicetta M; Morace G; Alema G; Mancini G
    Microbiologica; 1984 Jul; 7(3):273-7. PubMed ID: 6094987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-phase radioimmunoassay of herpes simplex virus IgG and IgM antibodies.
    Kalimo KO; Ziola BR; Viljanen MK; Granfors K; Toivanen P
    J Immunol Methods; 1977; 14(2):183-95. PubMed ID: 190320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement requirement of neutralizing antibodies in different classes of immunoglobulin appearing in rabbits and guinea pigs after primary and booster immunizations with herpes simplex virus.
    Shinkai K; Yoshino K
    Jpn J Microbiol; 1975 Feb; 19(1):25-34. PubMed ID: 169417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IgM, IgG and IgG subclass antibodies to herpes simplex virus in persons of different ages].
    Zazimko LA; Kuzenkova AV; Ivanova IA; Bashukova SS; Rybakov VP; Klimovich VB; Shitikova GS
    Vopr Virusol; 2000; 45(6):28-30. PubMed ID: 11200642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late 19S rabbit antibody neutralization test for differentiating herpes simplex virus types 1 and 2.
    Hampar B; Martos LM; Chakrabarty M; Burroughs MA
    J Immunol; 1970 Mar; 104(3):593-8. PubMed ID: 4314178
    [No Abstract]   [Full Text] [Related]  

  • 10. [Detection of IgG and IgM antibodies to herpes simplex virus type 1 and type 2 in human serum using an immunoenzyme method (ELISA) and the complement fixation reaction].
    Presecki V; Smerdel S; Delimar N
    Lijec Vjesn; 1989; 111(4-5):127-30. PubMed ID: 2549311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin class of antibody to herpes simplex virus in patients with oral cancer.
    Shillitoe EJ; Greenspan D; Greenspan JS; Silverman S
    Cancer; 1983 Jan; 51(1):65-71. PubMed ID: 6295594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic responses to herpes simplex virus in rabbits: complement-requiring neutralizing, conventional neutralizing, and passive hemagglutinating antibodies.
    Lerner AM; Shippey MJ; Crane LR
    J Infect Dis; 1974 Jun; 129(6):623-36. PubMed ID: 4365944
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of staphylococcal protein A with virus-IgG complexes.
    Austin RM; Daniels CA
    J Immunol; 1974 Nov; 113(5):1568-74. PubMed ID: 4371490
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
    Nemerow GR; Jensen FC; Cooper NR
    J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the neutralization of herpes simplex virus. X. Demonstration of complement-requiring neutralizing (CRN) and slow-reacting CRN (s-CRN) antibodies in late IgG.
    Yoshino K; Isono N; Tada A; Urayama M
    Microbiol Immunol; 1979; 23(10):975-85. PubMed ID: 229389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies specific for herpes simplex virus in human sera by the enzyme-linked immunosorbent assay.
    Gilman SC; Docherty JJ
    J Infect Dis; 1977 Oct; 136 Suppl():S286-93. PubMed ID: 198491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of herpes simplex virus (HSV) type-1 IgG and IgM antibodies by enzyme-linked immunosorbent assay (ELISA).
    Jordan J; Rytel MW
    Am J Clin Pathol; 1981 Oct; 76(4):467-71. PubMed ID: 6271004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to early and late antigens of herpes simplex virus type 1 in patients with oral cancer.
    Shillitoe EJ; Greenspan D; Greenspan JS; Silverman S
    Cancer; 1984 Jul; 54(2):266-73. PubMed ID: 6327004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of rheumatoid factor with infectious herpes simplex virus-antibody complexes.
    Ashe WK; Daniels CA; Scott GS; Notkins AL
    Science; 1971 Apr; 172(3979):176-7. PubMed ID: 4323251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the neutralization of herpes simplex virus. VII. Reevaluation of the equilibrium theory concerning the unneutralizable persistent fraction.
    Ide K; Yoshino K
    Jpn J Microbiol; 1974 Sep; 18(5):397-406. PubMed ID: 4374567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.